intravenous salin water

ApprovedSmall molecule

IInstituto Mexicano del Seguro Social

intravenous salin water is one of 29 small molecule programs targeting Mastectomy. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Oxidative StressActive, not recruiting

Oxidative StressApproved

Active, not recruiting

Competition

Competitive Landscape

138 competitors in Oxidative Stress

#DrugCompanyPhaseTrials

Kerendia

Bayer

Phase 3

1 2

Qvar

SSchering-Plough

Phase 3

1 3

Ascorbate

FFudan University

Phase 3

1 4

intravenous salin water

IInstituto Mexicano del Seguro Social

Approved

1 5

Niacin/laropiprant

Merck & Co.

Phase 3

1 6

Honey

SSohaib Ashraf

Phase 3

1 7

Bayer Aspirin

Bayer

Preclinical

1 8

Nicorette

Pfizer

Preclinical

1 9

Tractocile

GSK

Preclinical

1 10

Circadin

NNeurim Pharmaceuticals Ltd.

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2027

Post-ApprovalRecruiting

Oxidative Stress

NCT07073846

Clinical

Trials by Indication[1]

Oxidative Stress1 trial

Effect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery.

Recruiting·IInstituto Mexicano del Seguro Social·Phase 4·NCT07073846·104 enrolled

Mastectomy1 trial

Dexamethasone and Respiratory Function After Mastectomy

Completed·IInstituto Mexicano del Seguro Social·Phase 3·NCT02305173·120 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for intravenous salin water. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — intravenous salin water compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for intravenous salin water. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Instituto Mexicano del Seguro Social company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: IInstituto Mexicano del Seguro Social

intravenous salin water

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2027

Trials by Indication[1]

Oxidative Stress1 trial

Mastectomy1 trial

References

Drug Info

Quick Facts

Related News